AR and prostate carcinoma: To elucidate the potential mechanisms of the involvement of PMEPA1-a and PMEPA1-b in aggressive disease progression, we conducted a comparative study to assess the effects of PMEPA1 isoforms (a and b) on prostate cancer cell growth and signaling pathways of AR and TGF-β.